Home Odonate

Odonate

In operation
IPO
Developer of Novel Chemotherapy Drugs

Basic Information

Odonate is a pharmaceutical company dedicated to developing first-class therapies to improve patient lives and extend the survival of cancer patients, with an initial focus on developing tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in cancer treatment.
Odonate Therapeutics, Inc.
SanDiego,California,United States of America
101~500 people
January 01, 2013
ir@odonate.com